Bone remodelling: A signalling system for osteoclast regulation

Two physiological regulators of osteoclast maturation have recently been identified: the secreted protein osteoprotegerin and the cell-surface ligand to which it binds. These proteins are likely to play an important part in the control of bone resorption, but are also likely to have important roles in other tissues.

[1]  E. Jimi,et al.  Regulation of Osteoclast Function , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[2]  A. Wetterwald,et al.  Role of CSF‐1 in bone and bone marrow development , 1997, Molecular reproduction and development.

[3]  John C. Lee,et al.  Osteoprotegerin Is a Receptor for the Cytotoxic Ligand TRAIL* , 1998, The Journal of Biological Chemistry.

[4]  S. Morony,et al.  osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. , 1998, Genes & development.

[5]  G Shimamoto,et al.  Osteoprotegerin: A Novel Secreted Protein Involved in the Regulation of Bone Density , 1997, Cell.

[6]  D. Lacey,et al.  Osteoprotegerin Ligand Is a Cytokine that Regulates Osteoclast Differentiation and Activation , 1998, Cell.

[7]  Brian R. Wong,et al.  TRANCE Is a Novel Ligand of the Tumor Necrosis Factor Receptor Family That Activates c-Jun N-terminal Kinase in T Cells* , 1997, The Journal of Biological Chemistry.

[8]  R. Derynck,et al.  Increased expression of TGF-beta 2 in osteoblasts results in an osteoporosis-like phenotype , 1996, The Journal of cell biology.

[9]  S. Mochizuki,et al.  Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro. , 1998, Endocrinology.

[10]  L. Banks,et al.  Effect of degenerative spinal and aortic calcification on bone density measurements in post‐menopausal women: links between osteoporosis and cardiovascular disease? , 1994, European journal of clinical investigation.

[11]  S. Marsters,et al.  Induction of Apoptosis by Apo-2 Ligand, a New Member of the Tumor Necrosis Factor Cytokine Family* , 1996, The Journal of Biological Chemistry.

[12]  R. Steinman,et al.  TRANCE (Tumor Necrosis Factor [TNF]-related Activation-induced Cytokine), a New TNF Family Member Predominantly Expressed in T cells, Is a Dendritic Cell–specific Survival Factor , 1997, The Journal of experimental medicine.

[13]  S A Goldstein,et al.  Osteoporosis induced in mice by overproduction of interleukin 4. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[14]  R. Dubose,et al.  A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function , 1997, Nature.

[15]  A. Reddi.  Bone Morphogenesis and Modeling: Soluble Signals Sculpt Osteosomes in the Solid State , 1997, Cell.

[16]  Y. Kokai,et al.  Overexpression of the granulocyte colony-stimulating factor gene leads to osteoporosis in mice. , 1996, Laboratory investigation; a journal of technical methods and pathology.

[17]  C A Smith,et al.  Identification and characterization of a new member of the TNF family that induces apoptosis. , 1995, Immunity.

[18]  G. Daculsi,et al.  Cytokines, growth factors and osteoclasts. , 1998, Cytokine.

[19]  K Yano,et al.  Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[20]  N. Udagawa,et al.  Modulation of osteoclast differentiation by local factors. , 1995, Bone.

[21]  R. Derynck,et al.  Toward a molecular understanding of skeletal development , 1995, Cell.

[22]  S. Nishikawa,et al.  The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene , 1990, Nature.

[23]  J. Caamaño,et al.  Osteopetrosis in mice lacking NF-κB1 and NF-κB2 , 1997, Nature Medicine.

[24]  M. Cecchini,et al.  Recent developments in the understanding of the pathophysiology of osteopetrosis. , 1996, European journal of endocrinology.

[25]  M. Noble,et al.  Generation of osteoclast-inductive and osteoclastogenic cell lines from the H-2KbtsA58 transgenic mouse. , 1993, Proceedings of the National Academy of Sciences of the United States of America.